External dataset validation and functional experiments confirmed that silencing BAMBI, MAPK8IP2, or BMP7 directly altered oxaliplatin sensitivity in CRC cell lines, supporting their potential as predictive biomarkers. This evidence concerns the gene BMP7 and colorectal carcinoma.